Some aspects of the etiology of non-Hodgkin's lymphoma

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 2, 1998, Pages 679-681

  Hardell, Lennart ^a   Lindström, Gunilla ^b   Van Bavel, Bert ^b   Fredrikson, Mats ^c   Liljegren, Göran ^a  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chlordanes; Chlorophenols; Dioxins; Etiology; Immunosuppression; Non Hodgkin's lymphoma; Organic solvents; Phenoxyacetic acids; Polychlorinated biphenyls; Viruses

Indexed keywords

BENZENE; CHLORDANE; CHLOROPHENOL; DIOXIN; IMMUNOSUPPRESSIVE AGENT; ORGANIC SOLVENT; PHENOXYACETIC ACID DERIVATIVE; POLYCHLORINATED BIPHENYL;

CONFERENCE PAPER; HUMAN; IMMUNE DEFICIENCY; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0031804084     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106679     Document Type: Conference Paper

References (44)

1. Rabkin CS, Devesa S, Hoar Zahm S, Gail MH. Increasing incidence of non-Hodgkin's lymphoma. Sem Hematol 30:286-296 (1993).
2. Hardell L. Malignant lymphoma of histiocytic type and exposure to phenxoyacetic acids or chlorophenols. Lancet i:55-56 (1979).
3. Hardell L, Eriksson M, Lenner P, Lundgren E. Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: a case-control study. Br J Cancer 43:169-176 (1981).
4. Hardell L, Bengtsson NO. Epidemioloeical study of socioeconomic factors and clinical findings in Hodgkin's disease, and reanalysis of previous data regarding chemical exposure. Br J Cancer 48:217-225 (1984).
5. Hardell L, Eriksson M, Degerman A. Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of nonHodgkin's lymphoma. Cancer Res 54: 2386-2389 (1994).
6. Haraell L, Eriksson M, Axelson O, Hoar-Zahm S. Cancer epidemiology. In: Dioxins and Health (Schecter A, ed). New York:Plenum Press, 1994;525-547.
7. Yin S-N,Hayes RB, Linet MS, Li G-L, Dosemeci M, Travis LB, Zhang Z-N, Li D-G, Chow W-H, Wacholder S, et al. An expanded cohort study of cancer among benzene-exposed workers in China. Environ Health Perspect 104(Suppl 6):1339-1341 (1996).
8. Hayes RB, Yin SN, Dosemeci M, Li GL, Wacholder S, Chow WH, Rothman N, Wang YZ, Dai TR, Chao X-J, et al. Mortality among benzene-exposed workers in China. Environ Health Perspect 104(Suppl 6):1349-1352 (1996).
9. Hardell L, Fredrikson M, Eriksson M, Hansson M, Rappe C. Adipose tissue concentrations of dioxins and dibenzofurans in patients with malignant lymphoproliferative diseases and in patients without a malignant disease. Eur J Cancer Prev 4:225-229 (1995).
10. Hardell L, van Bavel B, Lindström G, Fredrikson M, Hagberg H, Liljegren G, Nordström M, Johansson B. Higher concentrations of specific polychlorinated biphenyl congeners in adipose tissue from non-Hodgkin's lymphoma patients compared with controls without a malignant disease. Int J Oncol 9:603-608 (1996).
11. Hardell L, Liljegren G, Lindström G, van Bavel B, Broman K, Fredrikson M, Hagberg H, Nordström M, Johansson B. Increased concentrations of chlordane in adipose tissue from non-Hodgkin's lymphoma patients compared with controls without a malignant disease. Int J Oncol 9:1139-1142 (1996).
12. Tojo Y, Wariisni M, Suzuki Y, Nishiyama K. Quantification of chlordane residues in mother's milk. Arch Environ Contam Toxicol 15:327-332 (1986).
13. Rappe C. Sources of exposure, environmental concentrations and exposure assessment of PCDDs and PCDFs. Chemosphere 27:221-225 (1993).
14. Rothman N, Cantor KP, Blair A, Bush D, Brock JW, Helzlsoure K, Zahm SH, Needham LL, Pearson GR, Hoover RN, et al. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 350:240-244 (1997).
15. Lu YC, Wu YC. Clinical findings and immunological abnormalities in Yu-Cheng patients. Environ Health Perspect 59:17-29 (1985).
16. McConnachie PR, Zahalasky AC. Immune alterations in humans exposed to the termicicide technical chlordane. Arch Environ Health 47:295-301 (1992).
17. Vos JG, Moore JA, Zinkl JG. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals. Environ Health Perspect 5:149-162 (1973).
18. Tonn T, Esser C, Schneider EM, Steinmann-Steiner-Haldenstätt W, Gleichmann E. Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachloro-p-dioxin. Environ Health Perspect 104:422-426 (1996).
19. Kerkvliet NI, Brauner TA, Mechanisms of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD)-induced humoral immune suppression: evidence of primary defect in T-cell regulation [published erratum appears in Toxicol Appl Pharmacol 89:148 (1987)]. Toxicol Appf Pharmacol 87:18-31 (1987).
20. Exon JH, Koller LD. Effects of chlorinated phenols on immunity in rats. Int J Immunopharmacol 7:239-247 (1985).
21. Daniel V, Huber W, Bauer K, Opelz G. Impaired in-vitro lymphocytes responses in patients with elevated pentachlorophenol (PCP) blood levels. Arch Environ Health 50:287-292 (1995).
22. Sharma RP, Reddy RV. Toxic effects of chemicals on the immune system. In: Handbook of Toxicology (Haley TJ, ed). Washington:Hemisphere Publishing, 1987;423-435.
23. +)T lymphocytes in workers exposed to benzidine and beta-naphthylamine. Arch Environ Health 50:196-199 (1995).
24. Faustini A, Settimi L, Pacifici R, Fano V, Zuccaro P, Forastiere F. Immunological changes among farmers exposed to phenoxy herbicides: preliminary observations. Occup Environ Med 53:583-585 (1996).
25. Miller RA. The aging immune system: primer and prospectus. Science 273:70-74 (1996).
26. Blomberg J, Möller T, Olsson H, Anderson H, Jonsson M. Cancer morbidity in blood recipients-results of a cohort study. Eur J Cancer 29A:2101-2105 (1993).
27. Spector B, Perry GS III, Kersey JH. Genetically determined immunodeficiency disease and malignancy: report from the Immunodeficiency Registry. Clin Immunol Immunopathol 11:12-19 (1978).
28. Isomäki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J Chron Dis 31:691-696 (1978).
29. Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 32A:1753-1757 (1996).
30. Kassan SS, Thomas TL, Moutsopoulus HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM. Increased risk of lymphoma in Sicca Syndrome. Ann Intern Med 89:888-892 (1978).
31. Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 51:437-439 (1992).
32. Hoover R, Fraumeni JF, Jr. Risk of cancer In renal-transplant recipients. Lancet ii:55 (1973).
33. Kinlen LJ, Shell AGR, Peto J, Doll R. Colloborative United Kingdom-Australiasian study of cancer in patients treated with immunosuppressive drugs. Br Med J II:1461-1466 (1979).
34. Purtilo D. Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virus, Ann Intern Med 105: 668-679 (1986).
35. Cruz PD Jr. Ultraviolet B (UVB)-induced immunosuppression: biologic, cellular, and molecular effects. Adv Dermatol 9:79-94 (1994).
36. Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF Jr. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 88:298-300 (1996).
37. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. Br Med J 314:1451-1455 (1997).
38. Klein G, Immunovirology of transforming viruses. Curr Opin Immunol 3:665-673 (1991).
39. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B-lymphocytes. J Virol 66:122-131 (1992).
40. Potter M. Pathogenetic mechanisms in B-cell non-Hodgkin's lymphoma in humans. Cancer Res 52(Suppl):5522s-5528s (1992).
41. Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-Cell Malignancy Study Group. Int J Cancer 45:237-243 (1990).
42. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE, et al. Non-Hodgkin's lymphoma in 90 homosexual men: relationship to generalized lymphadenopathy and acquired immunodeficiency syndrome. N Engl J Med 311:565-570 (1984).
43. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 69: Polychlorinated Dibenzo-para-Dioxin and Polychlorinated Dibenzofurans. Lyon:International Agency for Research on Cancer, 1997.
44. Manzari V, Gismondi A, Barillari G, Morrone S, Modesti A, Albonici L, De Marchis L, Fazio V, Gradilone A, Zani M et al. HTLV-V: a new human retrovirus isolated in a TAC-negative T-cell lymphoma/leukemia. Science 238:1581-1583 (1987).